
TSE:MFC
This summary was created by AI, based on 27 opinions in the last 12 months.
Manulife Financial (MFC) is viewed positively by numerous analysts, with many highlighting its robust growth potential, especially in the Asian market and wealth management. The company has successfully increased its dividend yield, currently sitting at approximately 4-5%, while its price-to-earnings (PE) ratio remains attractive compared to peers in the banking sector. Analysts have noted concerns over potential earnings drops but maintain a long-term positive outlook, suggesting that MFC is suitable for income-focused investors. While many emphasize the reliability of MFC's dividend and its strong position in life insurance, there are mixed feelings regarding its growth prospects compared to other financial institutions. Overall, the sentiment leans towards MFC being a solid choice for those seeking steady income and moderate growth, but some experts advise caution regarding market volatility.
The whole insurance/financial sector is suffering from near zero interest rates. This is incredibly well positioned in Asia and the US. Feels the shares truly have a 50% appreciation over the next 3 years or so. Expects to see dividend increases next year. All the policies written today, are based on very low interest rates. They have cleaned themselves up after the financial crisis, and it is a cheap stock.
3 to 10 Year Hold? Lifecos have long tails. It’s not like car insurance where every year rates are redone. Life insurance policies are for 5-10-20 years, so repricing is very difficult for them. They used to invest in bonds to cover liabilities, but can’t do that as easily anymore because rates are so low, which is pushing them into riskier parts of the investment curve. They missed their numbers by about 13%, although Asia did well for them. Not expensive, but doesn’t see how they make a lot of money going forward. He would rather own a bank for that time horizon.
Lifecos have assets and liabilities. Part of the overhang is the long end of the interest rate curve going down. They are investigating having to hold more cash on the balance sheet. Notwithstanding, they have hedges in place that mitigate short term exposure. The valuation should stay range bound for the short term.
(A Top Pick Oct 2/15. Down 9.85%.) He still likes this. It has visible earnings growth of 12% per annum over the next couple of years. It has 11% annual dividend growth. Operationally they did everything right, but their energy book was a real problem, which knocked down their BV per share. It is doing well in both its US and Asian operations. Thinks they can grow their dividend 11% year-over-year.
It is hard to find dividend paying stocks right now at relatively good valuations. This one is trading at less than BV with a yield of 4.08%. They have been increasing their dividend more aggressively recently. Longer-term, he likes their wealth management franchise as people move from saving for, to spending in retirement, and insurance companies are well-equipped to handle that.
(A Top Pick July 29/15. Down 19.79%.) People are a little concerned about its exposure to Asia and the slowdown that is occurring there. At this price you have the ability to buy a well-run insurance company that has de-risked its balance sheet greatly over the last number of years. It has changed its product mix to the extent that it is a lot less market sensitive than it used to be. Trading at less than BV, and is still a Buy.
This has not done well. There are a lot of headwinds in terms of energy loans in their energy bonds. Interest rates not going up is not good for lifecos. It’s a cheap stock. Longer-term, she likes their positioning in Asia, and about a 3rd of their revenues are from there. This is one you might be open to pick at and build a position in. Pretty cheap now.